Skip to content

Clinical trials

Phase 2 Stroke trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 2 Country / region: Canada Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20031
20042
20053
20061
20072
20083
20093
20113
20131
20142
20151
20181
20191
20201
20211
20221
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated7
Unknown status3
Recruiting2
Withdrawn2
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Alberta6
University of Calgary3
GlaxoSmithKline2
Hamilton Health Sciences Corporation2
NoNO Inc.2
Stem Cell Therapeutics Corp.2
University Health Network, Toronto2
ARCA Biopharma, Inc.1
Allergan1
Anthos Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke34
Ischemic Stroke9
Atrial Fibrillation3
Cerebral Hemorrhage3
Thrombosis3
Brain Ischemia2
Cerebral Infarction2
Hypertension2
Intracranial Hemorrhages2
Bites and Stings1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.